In-Q-Tel

NEW YORK (GenomeWeb News) – Claremont BioSolutions said today it has entered a strategic partnership with investment firm In-Q-Tel to accelerate commercialization of Claremont's Prep-on-a-Chip sample preparation platform.

This article was originally published May 7.

NEW YORK (GenomeWeb News) – OpGen today announced a collaboration with In-Q-Tel to develop a high-throughput sequence and genome mapping pipeline for microbial genome analysis.

Quanterix said this week that it has received an investment of an undisclosed amount from In-Q-Tel, a non-profit investment firm that delivers technology to the US intelligence community.

The undisclosed investment will support the development of a platform for US intelligence applications that will rely on Biomatrica's technology that enables biological samples to be stored at room temperature.

The investment expands Arxcis' ongoing collaboration with IQT to develop Arcxis' fully automated RNA and DNA sample-preparation device, expected to launch later this year.

MBI plans to use the series B venture funding to develop its Apollo sample prep technologies.

Arcxis received an undisclosed investment from In-Q-Tel, which it will use to accelerate development and commercialization of its nucleic acid sample preparation platform and diagnostic consumable product line.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.